Kenneth Hillan Insider Trading $ZYME Zymeworks Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Kenneth Hillan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Kenneth Hillan. Kenneth Hillan is Director in SANGAMO THERAPEUTICS, INC ($SGMO) and Chief Executive Officer in Achaogen Inc ($AKAO) and See Remarks in Achaogen Inc ($AKAO) and Director in Zymeworks Inc. ($ZYME) and Director in Relypsa Inc ($RLYP).

Kenneth Hillan in Zymeworks Inc.

Trading Symbol: ZYME
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth Hillan: Director
Holdings: 0 shares
Latest Transaction: May 07 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Kenneth Hillan in Zymeworks Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AKAO, RLYP, SGMO, ZYME

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 07 2021ZYMEZymeworks Inc.Hillan Kenneth J.DirectorOption ExerciseA29.499,000265,4109,000
May 12 2020ZYMEZymeworks Inc.Hillan Kenneth J.DirectorOption ExerciseA35.499,000319,4109,000
May 08 2019ZYMEZymeworks Inc.Hillan Kenneth J.DirectorOption ExerciseA19.1110,000191,10010,000

Page:   1